Avatar

Minh Nguyen, PA-C, MHS

(she/her)
  • Pediatric Hematology Oncology

About

Minhdan Nguyen, PA-C, is a board-certified Physician Assistant whose career has been devoted entirely to the field of oncology. A graduate of Duke University’s Physician Assistant program, she spent over a decade specializing in the treatment of primary and secondary brain cancers. During this time, she served as a sub-investigator on numerous clinical trials, advanced to the role of Director of Clinical Care within her practice, and led her team as the Advanced Practice Provider (APP) Lead.

In 2025, Minhdan transitioned to pediatric hematology oncology at UCLA, where she helped establish a newly dedicated APP team to provide 24/7 inpatient coverage for pediatric Hem/Onc services. She is also an active member of the California Academy of Physician Associates and serves as the DEI Subcomittee Chair. 

Languages

English

Education

Medical Board Certification

Physician Assistant, National Commission on Certification of Physician Assistants, 2013

Degree

MHS, Duke University School of Medicine, 2013

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Mattel Children's Hospital

Research

Publications

  1. Nguyen, M, Truong, J, Saria, M, Kesari, S. “Clinical and Social Challenges & Opportunities in Treating Glioblastoma with Tumor Treatment Fields, a Case Series." Poster Society of Neuro Oncology, 2017.
  2. Juarez, T., Boucher, N., Heng, A., Gill, J., Nguyen, M., Truong, J., Saria, M., Achrol, A., Barkhoudarian, G., Kelly, D., Kesari, S. “A Phase I Dose Escalation and Central Nervous System Pharmacokinetic Study of Pulsatile Afatinib in Patients with Brain Cancer.” Neuro Oncology Vol 19, 2017.
  3. Juarez, T., Boucher, N., Heng, A., Gill, J., Nguyen, M., Truong, J., Saria, M., Achrol, A., Barkhoudarian, G., Kelly, D., Kesari, S. “A Phase II Study of Tumor Treating Fields (TTFields).” Neuro Oncology Vol 19, 2017.
  4. Piccioni, D., Achrol, A., Kiedrowski, L., Banks, K., Boucher, N., Barkhoudarian, G., Kelly, D., Juarez, T., Lanman, R., Raymond, V., Nguyen, M., Truong, J., Heng, A., Gill, J., Saria, M., Pingle, S., Kesari, S. “Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors.” CNS Oncology Vol 8, No 2, 2019.
  5. Singh, V., Fisher, D., Schultz, R., Mayer, J., Boorgula, S., Gill, J., Nguyen, M., Truong, J., Dobrawa, L., Arganda Carrillo, J., Wagle, N., Kesari; S. “TargetSelector™ cerebrospinal fluid (CSF) circulating tumor cells and biomarker analysis: improving sensitivity and targeted treatment options in breast and NSCLC cancer patients with CNS involvement.” Abstract, Society of Neuro Oncology Conference, 2020.
  6. Yalamanchi, M., Sharma, A., Nguyen, M., Truong, J., Carrillo, J., Wagle, N., Gill, J., Kesari, S. “Successful and durable response of primary CNS T-Cell lymphoma to upfront temozolomide monotherapy." Leukemia & Lymphoma, 2021.
  7. Yalamanchi, A., Gill, J., Truong, J., Nguyen, M., Carrillo, J., Wagle, N., Sharma, A., Kesari, S. “Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report.” Annals of Clinical and Translational Neurology, 2021.
  8. Nguyen, M., Truong, J., Sharma, A., Kesari, S., Carrillo, J., Chow, J., Landa, E., Griffiths, E., Kelly, D., Wagle, N. “Case report of Cisplatin + Etoposide for the Treatment of Metastatic Malignant Meningioma."  Poster Society of Neuro Oncology, 2021.
  9. Wagle, N., Barkhoudarian, G., Chaiken, L., Wollman, R., Sharma, A., Carrillo, J., Nguyen, M., Truong, J., Chow, J., Chacon, E., Juarez, T., and Kesari, S. “Recurrent Glioblastoma Treated with Maximal Safe Neurosurgical Resection, Intra-Operative Radiation Therapy  (IORT) Using the Xoft® Axxent® Electronic Brachytherapy System (GLIOX) and Post-Radiation Adjuvant Bevacizumab. Feasibility and Safety data report." Poster Society of Neuro Oncology, 2022.
  10. Kesari, S., Wojcinski, A., Pabla, S., Seager, R.J., Gill, J.M., Carrillo, J., Wagle, N., Park, D., Nguyen, M., Truong, J., Takasumi, Y., Chaiken, L., Chang, SC., Barkhoudarian, B., Kelly, D.F., Juarez, T. “Pre-Radiation Checkpoint Inhibitors in Newly Diagnosed High-Grade Glioma.” Journal for ImmunoTherapy of Cancer, 2023.

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.